Edwards Lifesciences Corporation 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Leslie C. Davis

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Leslie C. Davis”): 461,819,765 for, 13,184,241 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 185,548,816 for, 564,216 against, 41,651 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: David T. Feinberg, MD

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: David T. Feinberg, MD”): 473,746,144 for, 1,812,520 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 186,093,251 for, 19,791 against, 41,644 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Kieran T. Gallahue

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Kieran T. Gallahue”): 457,045,403 for, 18,518,195 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 186,066,233 for, 46,808 against, 41,644 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Leslie S. Heisz

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Leslie S. Heisz”): 454,955,195 for, 20,567,869 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 186,081,692 for, 31,351 against, 41,644 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Paul A. LaViolette

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Paul A. LaViolette”): 428,701,646 for, 45,445,276 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 185,524,194 for, 588,826 against, 41,666 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Steven R. Loranger

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Steven R. Loranger”): 446,216,434 for, 28,909,945 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 185,524,867 for, 588,168 against, 41,650 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Ramona Sequeira

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Ramona Sequeira”): 474,260,552 for, 1,295,682 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 186,093,257 for, 19,786 against, 41,644 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Nicholas J. Valeriani

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Nicholas J. Valeriani”): 441,224,095 for, 34,327,820 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 185,679,590 for, 433,452 against, 41,644 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Election of Directors: Bernard Zovighian

Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Bernard J. Zovighian”): 459,179,727 for, 16,257,009 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Item 5.07 Submission of Matters to a Vote of Security Holders The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows: Proposal 1 : All the nominees for director listed in Proposal 1 were elected to serve u…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 168 asset managers below reported 186,093,029 for, 20,009 against, 41,645 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.

Description as filed by funds: Approval of the Amended and Restated Long- Term Stock Incentive Compensation Program

Edwards Lifesciences Corporation’s own tally for this item (“4. Approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program”): 456,675,201 for, 19,210,539 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 : The approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Edwards Lifesciences Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 158 managers: 184,669,460 for, 422,765 against, 41,646 abstained, 441 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 16 managers: 10,914,811 for, 794 against, 390 unknown.

Description as filed by funds: Advisory Vote to Approve Named Executive Officer Compensation

Edwards Lifesciences Corporation’s own tally for this item (“2. Advisory proposal regarding the Company's named executive officer compensation”): 424,961,639 for, 50,924,101 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Edwards Lifesciences Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approval, on an advisory basis, of the named executive officer compensation disclosed in the attached Proxy Statement” (3 managers, 99 for, 30,566 not voted); “Say on Pay” (2 managers, 855,586 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 164 managers: 185,200,180 for, 391,582 against, 41,646 abstained, 441 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 910 managers: 263,232,143 for, 36,550,700 against, 5,743 abstained, 367,148 not voted, 390 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of Appointment of Independent Registered Public Accounting Firm

Edwards Lifesciences Corporation’s own tally for this item (“3. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 446,283,142 for, 56,814,075 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 : Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as set forth below:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 169 asset managers below reported 183,479,008 for, 2,645,244 against, 41,643 abstained, 441 not voted, 390 unknown.

Showing the 25 largest of 169 asset managers. See all 169 in the interactive database.